Free radicals generated by xanthine/xanthine oxidase system augment nitric oxide synthase (NOS) and cyclooxygenase (COX)-independent component of bradykinin-induced vasodilatation in the isolated guinea pig heart

Pharmacological Reports

Volumn 58, Issue 3, 2006, Pages 405-412

  Kozlovski, Valery I ^a   Olszanecki, Rafal ^a   Chlopicki, Stefan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bradykinin; Guinea pig; Isolated heart; Oxygen free radicals; Xanthine oxidase

Indexed keywords

ACETYLCHOLINE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CYCLIC GMP; FREE RADICAL; ICATIBANT; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DRUG MECHANISM; FEMALE; GUINEA PIG; ISOLATED HEART; MALE; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; UPREGULATION;

EID: 33746334484     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Abrescia P, Golino P: Free radicals and antioxidants in cardiovascular diseases. Expert Rev Cardiovasc Ther, 2005, 3, 159-171.
2. Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, Stewart G et aL: Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol, 2005, 39, 531-536.
3. Berry CE, Hare JM: Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol, 2004, 555, 589-606.
4. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000, 87, 840-844.
5. Capdevila JK Falck JR, Estabrook RW: Cytochrome P450 and the arachidonate cascade. FASEB, J. 19929 6, 731-736.
6. Chlopicki S, Gryglewski RJ: The endothelium-dependent and the endothelium-independent vasodilators in the isolated, perfused guinea pig heart. J Physiol Pharmacol, 1992, 43, 353-365.
7. Chlopicki S, Gryglewski RJ: Nitric oxide is a major mediator in reactive hyperaemia evoked by a brief coronary occlusion in the guinea pig heart. Eur J Pharmacol, 1993, 241, 117-120.
8. Chlopicki S, Lomnicka M, Gryglewski RJ: Reversal of the postischaemic suppression of coronary function in perfused guinea pig heart by ischaemic preconditioning. J Physiol Pharmacol, 1999, 50, 605-615.
9. 2+ influx. Circ Res, 1999, 84, 210-219.
10. + but may be due to spread of current from the endothelium in guinea pig arterioles. Am J Physiol Heart Circ Physiol, 2001, 280, H2478-H2483.
11. + currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J Physiol, 2001, 531, 359-373.
12. Dambrova M, Chlopicki S, Liepinsh E, Kirjanova O, Gorshkova O, Kozlovski VI, Uhlen S et al.: The methylester of gamma-butyrobetaine, but not gamma-butyrobetaine itself, induces muscarinic receptor-dependent vasodilatation. Naunyn Schmiedebergs Arch Pharmacol, 2004, 369, 533-539.
13. de Jong JW, Schoemaker RG, de Jonge R, Bernocchi P, Keijzer E, Harrison R, Sharma HS, Ceconi C: Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol, 2000, 32, 2083-2089.
14. Dusser DJ, Djokic TD, Borson DB, Nadel JA: Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J Clin Invest, 1989, 84, 900-906.
15. Eckman DM, Hopkins N, McBride C, Keef KD: Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid. Br J Pharmacol, 1998, 124, 181-189.
16. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation, 2002, 106, 221-226.
17. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I: Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension, 2000, 36, 270-275.
18. Fitzpatrick FA: Cyclooxygenase enzymes: regulation and function. Curr Pharm Des, 2004, 10, 577-588.
19. Frein D, Schildknecht S, Bachschmid M, Ullrich V: Redox regulation: A new challenge for pharmacology. Biochem Pharmacol, 2005, 70, 811-823
20. Friebe A and Koesling D: Regulation of nitric oxidesensitive guanylyl cyclase. Circ Res, 2003, 93, 96-105.
21. Giors M, Lacaria A, Lerda S, Manassero F, Martini W, Panero B, Penna C: Coronary reactive hyperaemia after nitric oxide inhibition in the anaesthetized goat. Boll Soc Ital Biol Sper, 1997, 73, 39-46.
22. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986, 320, 454-456.
23. Guan W, Osanai T, Kamada T, Hanada H, Ishizaka H, Onodera H, Iwasa A, Fujita N et al.: Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol, 2003, 41, 699-705.
24. Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G et al.: The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol, 2002, 40, 1232-1240.
25. Hewinson J, Stevens CR, Millar TM: Vascular physiology and pathology of circulating xanthine oxidoreductase: from nucleotide sequence to functional enzyme. Redox Rep, 2004, 9, 71-79.
26. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, Freeman BA: Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem, 1999, 274, 4985-4994.
27. 2 contribute to reactive dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol, 2004, 287, H2461-H2467.
28. Kuga T, Egashira Y, Mohri M, Tsutsui H, Harasawa Y, Urabe Y, Ando sincerely et al: Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation, 1995, 92, 183-189.
29. Landmesser U, Drexler H: Allopurinol and endothelial function in heart failure: future or fantasy? Circulation, 2002, 106, 173-175.
30. Losano G, Pagliaro P, Gattullo D, Marsh NA: Control of coronary blood flow by endothelial release of nitric oxide. Clin Exp Pharmacol, Physiol, 1994, 21, 783-789.
31. Marceau F, Hess JF, Bachvarov DR: The B1 receptors for kinins. Pharmacol Rev, 1998, 50, 357-386.
32. McCord JM, Omar BA: Sources of free radicals. Toxicol Ind Health, 1993, 9, 23-37.
33. Medeiros R, Cabrini DA, Ferreira J, Fernandes ES, Mori MA, Pesquero JB, Bader M et al.: Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for nitrogen-activated protein kinase and nuclear factor-kappaB signaling pathways. Circ. Res, 2004, 94, 1375-1382.
34. Mutafova-Yambolieva VN, Keef KD: Adenosine-induced hyperpolarization in guinea pig coronary artery involves A2b receptors and KATP channels. Am J Physiol, 1997, 273, H2687-H2695.
35. Olszanecki R, Kozlovski VI, Chlopicki S, Gryglewski RJ: Paradoxical augmentation of bradykinin-induced vasodilatation by xanthine/xanthine oxidase-derived free radicals in isolated guinea pig heart. J Physiol Pharmacol, 2002, 53, 689-699.
36. + channels in the sustained coronary vasodilator response to adenosine in dogs. Eur J Pharmacol, 1993, 231, 183-189.
37. Parkington HC, Tonta MA, Coleman HA, Tare M: Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle. J Physiol, 1995, 484, 469-480.
38. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P: Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol, 2002, 193, 275-286.
39. Sato A, Sakuma I, Gutterman DD: Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol, 2003, 285, H2345-H2354.
40. Simmons DL, Botting RM, Hla T: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev, 2004, 56, 387-437.
41. + channels. Stroke, 1997, 28, 2290-2294.
42. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L et al.: Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation, 2002, 105, 1429-1435.
43. Stewart AG, Piper PJ: Vasodilator actions of acetylcholine, A23187 and bradykinin in the guinea-pig isolated perfused heart are independent of prostacyclin. Br J Pharmacol, 1988, 95, 379-384.
44. Tare M, Parkington HC, Coleman HA: EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br J Pharmacol, 2000, 130, 605-618.
45. Wolin MS, Ahmad M, Gupte SA: The sources of oxidative stress in the vessel wall. Kidney Int, 2005, 67, 1659-1661.
46. Yang M, Yang Y, Zhang S, Kahn AM: Insulin-stimulated hydrogen peroxide increases guanylate cyclase activity in vascular smooth muscle. Hypertension, 2003, 42, 569-573.
47. Zou M, Yesilkaya A, Ullrich V: Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metab Rev, 1999, 31, 343-349.